跳至主要内容
临床试验/CTRI/2025/04/084100
CTRI/2025/04/084100招募中2 期

A Randomised Controlled Clinical Trial to study the effect of Til taila kaval in the management of Dantaharsha with special reference to Dental hypersensitivity.

Dr.Akshay Balu Pagare1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年4月17日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
70
试验地点
1
主要终点
To study the effect of til taila kaval in the management of dantaharsha based on the assessment criteria before and after.

研究概览

简要总结

Dantaharsha defined as a dental disease, with pain in tooth and hypersensitivity.

Kaval or swishing of oil in mouth helps particles,and other debris.

The prevalence rate of dental hypersensitivity is 32%.

Til tail kaval has been selected.

Til (sesame seed ) is high in protein, vitamin B1, iron, calcium, phosphorus which help to strengthen the teeth and calcium makes it more stronger.

Age group 20 to 40 years. The number of patient will be selected and divided into 2 groups named Group A (trail) Group B (controlled)

Til tail kaval (trail)& Til tail gandoosh (controlled)

Both the drug’s will be admistered for 15 days observation done day 0, day 3 , day 5,day 7 & day 15

Summary will be drawn and whole thesis will be summarised

Conclusion will be drawn strictly on the basis of statistical Analysis and will be unbiased.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • Ptient having age between 20-40 years and irrespective of socioeconomic status, sex & religion.
  • Patient having sign and symptoms of dantaharsha mentioned in ayurvedic classics like pain, discomfort in the teeth, sensitivity to teeth as responses to certain stimuli such as hot and cold temperature.
  • Patient who will give written consent.

排除标准

  • Bleeding disorder.
  • Chronic carcinogen ulceration in oral cavity.
  • Person suffering from DM, TB, HIV, HbsAg positive.

结局指标

主要结局

To study the effect of til taila kaval in the management of dantaharsha based on the assessment criteria before and after.

时间窗: 7 Days

次要结局

  • Where the trial group stands in comparison with control group in reduction in signs and symptoms of dantaharsh.(18 months)

研究者

发起方
Dr.Akshay Balu Pagare
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Akshay Balu Pagare

SMBT Ayurved College and Hospital, Dhamangaon, Igatpuri, Nashik 422403

研究点 (1)

Loading locations...

相似试验